Stocklore

Northrop Grumman (NOC)

Defense & Aerospace · US stock

What changed in recent filings

  • Institutions — 3 added · 2 reduced13F · as of end of 2026 Q2

What changed in recent SEC filings — factual, not a buy/sell recommendation.

Northrop Grumman recent earnings releases

Based on SEC filings. The release date is the day the earnings filing (8-K) was accepted; for quarters where that filing was not found, the periodic report filing date is shown.

  • 26Q3Released Oct 20, 2026
    Revenue +6.7% YoY · EPS $7.89
    Released before the open: Oct 19 close → Oct 20 close, the stock moved +4.6% · over the same window, market +0.3% · sector +0.1%
  • 26Q2Released Jul 21, 2026
    Revenue +5.1% YoY · EPS $7.68
    Released before the open: Jul 20 close → Jul 21 close, the stock moved -2.2% · over the same window, market +0.8% · sector -0.5%
  • 26Q1Released Apr 21, 2026
    Revenue +4.4% YoY · EPS $6.14
    Released before the open: Apr 20 close → Apr 21 close, the stock moved -7.0% · over the same window, market -0.7% · sector -2.8%
  • 25Q4Released Jan 27, 2026
    Revenue +9.6% YoY · EPS $9.96
    Released before the open: Jan 26 close → Jan 27 close, the stock moved +2.7% · over the same window, market +0.4% · sector +1.4%

The next earnings release is estimated around Jan 26, 2027 (calculated from how long this company has taken between quarter end and filing; it is not a date announced by the company).

Institutions holding Northrop Grumman

How many of the institutions we track reported holding this stock, quarter by quarter.

max 7
2019 Q1 · 42019 Q2 · 52019 Q3 · 62019 Q4 · 62020 Q1 · 62020 Q2 · 52020 Q3 · 52020 Q4 · 52021 Q1 · 52021 Q2 · 42021 Q3 · 52021 Q4 · 52022 Q1 · 62022 Q2 · 72022 Q3 · 62022 Q4 · 72023 Q1 · 52023 Q2 · 62023 Q3 · 32023 Q4 · 42024 Q1 · 52024 Q2 · 52024 Q3 · 52024 Q4 · 52025 Q1 · 52025 Q2 · 42025 Q3 · 42025 Q4 · 42026 Q1 · 62026 Q2 · 6
19 Q122 Q326 Q2

2019 Q1: 4 → 2026 Q2: 6 institutions

Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.

Which institutions hold Northrop Grumman

Institutions we track that reported holding this stock in their most recent 13F.

  • National Pension Service (Korea)0.13% of portfolio · held as of 2019 Q1 or earlier
  • Capital World Investors0.30% of portfolio · held as of 2020 Q3 or earlier
  • Tudor Investment Corp0.03% of portfolio · since 2025 Q3
  • Bridgewater Associates0.01% of portfolio · since 2025 Q4
  • Caisse de depot (Quebec)0.05% of portfolio · since 2026 Q1
  • Soros Fund Management0.06% of portfolio · since 2026 Q1

Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.

Q2 2026 13F recap — stocks several institutions bought and sold together →

Company overview

A major defense company developing the B-21 stealth bomber, space systems, and missile defense.

What is the Defense & Aerospace sector?

Defense, aerospace, and government contracts. Benefits from geopolitical tension.

Northrop Grumman is classified under the Defense & Aerospace sector. See peers below.

Northrop Grumman key financials

Based on SEC filings · as of Sep 30, 2026

25.1%
0.77x
as of Sep 30, 2026

Tap a metric name to see its meaning in the glossary.

Northrop Grumman vs Defense & Aerospace sector benchmark

Median of 13 representative sector stocks · SEC filings · factual comparison (not advice)

Revenue growth (YoY)
6.5%vs benchmark 16.6%↓ below
Operating margin
11.4%vs benchmark 10.1%↑ above
Net margin
10.4%vs benchmark 8.2%↑ above
ROE
25.1%vs benchmark 11.9%↑ above

A simple comparison to the sector benchmark. Higher or lower doesn’t mean good/bad or buy/sell.

NOC revenue by segment summary

SEC 10-Q · segment totals cross-checked against total revenue

2026-06-30 revenue was $10.9B.

The largest segment is Products, 81.0% of revenue — a highly concentrated structure.

Full segment weights, YoY changes, and an AI synthesis are available in the detailed analysis.

ETFs holding Northrop Grumman

Per SEC N-PORT · 2026-06-30 · by weight · factual

XLIState Street(R) Industrial Select Sector SPDR(R) ETF
1.18%
VYMVANGUARD HIGH DIVIDEND YIELD INDEX FUND
0.29%
VTVVANGUARD VALUE INDEX FUND
0.27%
RSPInvesco S&P 500 Equal Weight ETF
0.19%
SPY
0.11%
VOOVANGUARD 500 INDEX FUND
0.11%
IVViShares Core S&P 500 ETF
0.11%
VTIVANGUARD TOTAL STOCK MARKET INDEX FUND
0.10%
ITOTiShares Core S&P Total U.S. Stock Market ETF
0.09%

NOC on Stocklore

  • Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
  • Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
  • 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
  • Sector-relative metrics — Valuation and growth compared with the Defense & Aerospace average
See full NOC analysis →

Peers · Defense & Aerospace

NOC FAQ

What is Northrop Grumman (NOC)?

A major defense company developing the B-21 stealth bomber, space systems, and missile defense.

What sector is Northrop Grumman in?

Northrop Grumman is classified under Defense & Aerospace. Defense, aerospace, and government contracts. Benefits from geopolitical tension.

What are Northrop Grumman's key financials?

As of Sep 30, 2026 in SEC filings: Revenue growth (YoY) 6.5%, Operating margin 11.4%, Net margin 10.4%, ROE 25.1%, Debt-to-equity 0.77x. Definitions and interpretation are available on Stocklore.

What are Northrop Grumman's main revenue segments?

The largest segment is Products, about 81.0% of revenue. Segment totals are cross-checked against total revenue from SEC filings.

Where can I analyze Northrop Grumman (NOC) stock?

On Stocklore you can see NOC's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.

Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.

Not an investment adviser and not personalized investment advice; not a discretionary management service. No trade recommendations, no target prices, no execution or brokerage. We do not recommend or guarantee any purchase, sale, or returns. Investment decisions and their outcomes are your own.

Stocklore · CEO Lee Seung-jae · Business reg. no. 764-36-01607 · E-commerce permit 2026-Jeonju Wansan-0476 · Tel +82-70-7954-4939 · S120, Rm 302, 3F, 21 Jungsanjungang-ro, Wansan-gu, Jeonju, Jeonbuk, Korea